Joel Streed (@JoelStreed)
Joel is manager of the team that creates content for the Mayo Clinic News Network. He is a former broadcast journalist and news director. Joel has been with Mayo Clinic since 2001, first as a contract employee and then officially joining the staff in 2006. In 2012 Joel accompanied a research team to Mt. Everest and reported on their studies of high-altitude athletes.
For children, the opioid epidemic can be about adults in their lives with opioid use disorder or accidental overdoses when a child finds their parent's[...]
Editor's Note: This article is the second in the Young Innovators series, originally published in Mayo Clinic's Alumni Magazine. Each article features Mayo Clinic trainee[...]
Every now and then, you hear about surprising finds at flea markets, yard sales or in an attic. Items that appear ordinary are actually extraordinary,[...]
Q: I'm pregnant, and I've heard that getting the COVID-19 vaccine is dangerous for the baby. Should I wait to get it until after I[...]
Editor's Note: This article is the first in the Young Innovators series, originally published in Mayo Clinic's Alumni Magazine. Each article features a Mayo Clinic[...]
Knowledge synthesis is a key component of health care delivery research in which all available evidence on a particular topic is summarized through comprehensive literature[...]
Today's parents face an almost constant bombardment of guidance, warnings, advice, anecdotal information and suppositions regarding their child's health and wellbeing. Even the most well-read[...]
Viral hepatitis, or inflammation of the liver, is one of the most common infectious diseases in the world. Hundreds of millions of people live with[...]
Throughout Mayo Clinic, innovation is the thread that weaves through countless initiatives aimed at improving patient care. While Mayo’s most cutting-edge discoveries are often widely[...]
Q: I've heard stories of people getting very sick from the vaccine. If I do decide to get it, do I run the risk of[...]
Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of survival after a[...]